{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:14:47Z","timestamp":1783937687747,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jiac.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T17:54:03Z","timestamp":1728669243000},"page":"102538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between inappropriate empirical antimicrobial therapy and mortality in gram-negative bloodstream infections in patients with febrile neutropenia and hematological malignancy"],"prefix":"10.1016","volume":"31","author":[{"given":"Ariel Fernando","family":"Fl\u00f3rez Ria\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4800-5810","authenticated-orcid":false,"given":"Oscar Juli\u00e1n","family":"Rojas Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigifredo","family":"Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-1871","authenticated-orcid":false,"given":"Isabel Cristina","family":"Ram\u00edrez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jiac.2024.10.006_bib1","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenic cancer patients","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00277-011-1247-7","article-title":"Risk factors for infection and treatment outcome of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy","volume":"91","author":"Kang","year":"2012","journal-title":"Ann Hematol"},{"issue":"Suppl 5","key":"10.1016\/j.jiac.2024.10.006_bib3","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.jiac.2024.10.006_bib4","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciz319","article-title":"Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance","volume":"70","author":"Martinez-Nadal","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jiac.2024.10.006_bib5","doi-asserted-by":"crossref","first-page":"878","DOI":"10.15537\/smj.2018.9.22824","article-title":"The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies","volume":"39","author":"Calik","year":"2018","journal-title":"Saudi Med J"},{"issue":"18","key":"10.1016\/j.jiac.2024.10.006_bib6","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.7150\/jca.50802","article-title":"A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy","volume":"12","author":"Chen","year":"2021","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.jiac.2024.10.006_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01744-21","article-title":"Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock","volume":"66","author":"Chumbita","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.jiac.2024.10.006_bib8","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2024.10.006_bib9","series-title":"Chronic kidney disease: assessment and management","year":"2021"},{"issue":"7","key":"10.1016\/j.jiac.2024.10.006_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2016.0286","article-title":"Screening yield of HIV antigen\/antibody combination and pooled HIV RNA testing for acute HIV infection in a high-prevalence population","volume":"315","author":"Peters","year":"2016","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2024.10.006_bib11","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"Elsayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jiac.2024.10.006_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00213-21","article-title":"Overview of changes to the clinical and laboratory standards Institute performance standards for antimicrobial susceptibility testing, M100, 31st edition","volume":"59","author":"Humphries","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12941-023-00561-7","article-title":"Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy","volume":"22","author":"Sathya Kumar","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"10325","key":"10.1016\/j.jiac.2024.10.006_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jiac.2024.10.006_bib15","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/cid\/ciu052","article-title":"The global challenge of carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancies","volume":"58","author":"Satlin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2024.10.006_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/10428194.2012.723210","article-title":"Emergence of carbapenem-resistant enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies","volume":"54","author":"Satlin","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.jiac.2024.10.006_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s15010-011-0201-x","article-title":"The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria","volume":"39","author":"De Rosa","year":"2011","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.jiac.2024.10.006_bib18","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/AAC.01365-09","article-title":"Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to gram-negative bacteria: a retrospective analysis","volume":"54","author":"Micek","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2024.10.006_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jmii.2013.07.009","article-title":"Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia","volume":"48","author":"Su","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s15010-019-01370-x","article-title":"Inappropriate initial antimicrobial therapy for hematological malignancies patients with Gram-negative bloodstream infections","volume":"48","author":"Tang","year":"2020","journal-title":"Infection"},{"issue":"7","key":"10.1016\/j.jiac.2024.10.006_bib21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1086\/322604","article-title":"Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients","volume":"33","author":"Collin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jiac.2024.10.006_bib22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/502158","article-title":"Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study","volume":"24","author":"Wisplinghoff","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.jiac.2024.10.006_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.diagmicrobio.2009.02.008","article-title":"Factors associated with mortality in bacteremic patients with hematologic malignancies","volume":"64","author":"Tumbarello","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.jiac.2024.10.006_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/AAC.01250-19","article-title":"Shock and early death in hematologic patients with febrile neutropenia","volume":"63","author":"Guarana","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2024.10.006_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijantimicag.2016.01.011","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: analysis of 50 cases","volume":"47","author":"Tofas","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.jiac.2024.10.006_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/AAC.00164-17","article-title":"Efficacy of \u00df-lactam\/\u00df-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum-\u00df-lactamase-producing enterobacteriaceae in hematological patients with neutropenia","volume":"61","author":"Gudiol","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2024.10.006_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijantimicag.2018.12.003","article-title":"Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia","volume":"53","author":"Ben-Chetrit","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.jiac.2024.10.006_bib28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ajh.24489","volume":"91","author":"Trecarichi","year":"2016","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.jiac.2024.10.006_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jiac.2024.10.006_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jiac.2024.10.006_bib32","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/jac\/dkv218","article-title":"Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study","volume":"70","author":"Andria","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jiac.2024.10.006_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cmi.2020.01.023","article-title":"Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study","volume":"26","author":"Giannella","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2024.10.006_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkae211","article-title":"Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study","author":"Ong","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jiac.2024.10.006_bib35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cmi.2020.01.025","article-title":"Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia","volume":"26","author":"Maskarinec","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14203","article-title":"Risk factors for positive follow-up blood cultures in Gram-negative bacteremia among immunocompromised patients with neutropenia","volume":"26","author":"Ranganath","year":"2024","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.10.006_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2021.115444","article-title":"Incidence and utility of follow-up blood cultures in cancer patients with gram-negative bacteremia","volume":"101","author":"Clemmons","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2024.10.006_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa110","article-title":"Risk factors for positive follow-up blood cultures in gram-negative bacilli bacteremia: implications for selecting who needs follow-up blood cultures","volume":"7","author":"Mitaka","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.jiac.2024.10.006_bib39","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/ciae068","article-title":"Persistent gram-negative bloodstream infection increases the risk of recurrent bloodstream infection with the same species","volume":"78","author":"Ankrah","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2024.10.006_bib40","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12879-017-2297-9","article-title":"Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias","volume":"17","author":"Micozzi","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib42","first-page":"1079","article-title":"Reduced mortality from KPC-K. pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K. pneumoniae","volume":"21","author":"Micozzi","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jiac.2024.10.006_bib43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijantimicag.2013.08.008","article-title":"Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience","volume":"42","author":"L\u00fcbbert","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.jiac.2024.10.006_bib44","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/jac\/dkw221","article-title":"Natural history and decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis","volume":"71","author":"Bar-Yoseph","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jiac.2024.10.006_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223122","article-title":"The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: a pre-post intervention study","volume":"14","author":"Verroken","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jiac.2024.10.006_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/ciw649","article-title":"The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis","volume":"64","author":"Timbrook","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jiac.2024.10.006_bib47","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/cid\/civ447","article-title":"Randomized trial of rapid multiplex polymerase chain reaction\u2013based blood culture identification and susceptibility testing","volume":"61","author":"Banerjee","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:47:40Z","timestamp":1738928860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24002794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1341321X24002794"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.10.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between inappropriate empirical antimicrobial therapy and mortality in gram-negative bloodstream infections in patients with febrile neutropenia and hematological malignancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102538"}}